Intervention Protocol

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents

  1. Ole Jakob Storebø1,2,3,*,
  2. Susanne Rosendal4,
  3. Maria Skoog5,
  4. Camilla Groth6,
  5. Torben Bille7,
  6. Kirsten Buch Rasmussen3,
  7. Erik Simonsen3,
  8. Christian Gluud8

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 16 MAY 2012

DOI: 10.1002/14651858.CD009885


How to Cite

Storebø OJ, Rosendal S, Skoog M, Groth C, Bille T, Buch Rasmussen K, Simonsen E, Gluud C. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No.: CD009885. DOI: 10.1002/14651858.CD009885.

Author Information

  1. 1

    Psychiatric Department, Region Zealand, Child Psychiatric Clinic, Holbaek, Denmark

  2. 2

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, Copenhagen, Denmark

  3. 3

    Region Zealand Psychiatry, Psychiatric Research Unit, Roskilde, Sjælland, Denmark

  4. 4

    Psychiatric Centre Copenhagan, Centre for Crisis and Disaster Psychiatry, Copenhagen, Denmark

  5. 5

    Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark

  6. 6

    Herlev University Hospital, Pediatric Department, Herlev, Denmark

  7. 7

    Holbaek Hospital, Pediatric Department, Holbaek, Denmark

  8. 8

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, The Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Ole Jakob Storebø, ojst@regionsjaelland.dk.

Publication History

  1. Publication Status: New
  2. Published Online: 16 MAY 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess beneficial and harmful effects of methylphenidate for children and adolescents with ADHD.